Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.87%
SPX
-0.51%
IXIC
-0.53%
FTSE
-1.19%
N225
+2.87%
AXJO
+0.31%
Cashu Logo
⌘K
Log In
HomeWatchlistNewsSignals
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Key Stats

Market Cap
21.38M
Dividend Yield
0.00%
P/E Ratio
-0.80
EPS
-0.72
Revenue
9.29M
Avg. Volume
7.62M

Recently from Cashu

publisher logo
Cashu

Cue Biopharma's Innovative Clinical Trials Transforming Immunotherapy for Cancer and Autoimmune Disorders

about 17 hours ago
publisher logo
Cashu

Please provide the content you would like summarized, and I'll help you with a title.

10 days ago
publisher logo
Cashu

It appears there's no content provided for summarization. Please share the text you'd like summarized.

12 days ago

About

What does CUE do?
Cue Biopharma, a Boston-based clinical-stage biopharmaceutical company, develops biologic drugs for immune system modulation to treat cancers and autoimmune disorders. Its key candidates include CUE-101 for HPV-positive HNSCC and CUE-102 for Wilms' Tumor 1 protein.
Sector
💻 Health Care
IPO
CEO
Employees
41
Headquarters
Massachusetts, USA
Website
http://www.cuebiopharma.com
Join our newsletter to keep up to date with us!
Stocks
Health Care
cue
Cue Biopharma
NASDAQ: CUE
-0.02 (-6.37%)
0.2542
USD
At close at Mar 18, 16:12 UTC
Summary
News
Signals
Benchmarks
Financials